ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101
Oral Oncology
◽
10.1016/j.oraloncology.2020.105171
◽
2021
◽
Vol 114
◽
pp. 105171
Author(s):
Michael J. Jelinek
◽
Nathan R. Foster
◽
Alex J. Zoroufy
◽
Gary K. Schwartz
◽
Pamela N. Munster
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Neck Squamous Cell Carcinoma
◽
Polymerase Inhibitor
Download Full-text
Related Documents
Cited By
References
Elderly patients with locally advanced head and neck squamous cell carcinoma treated with NBTXR3 nanoparticles activated by radiotherapy: A phase I trial
Annals of Oncology
◽
10.1093/annonc/mdy287.014
◽
2018
◽
Vol 29
◽
pp. viii377-viii378
Author(s):
C. Le Tourneau
◽
V. Calugaru
◽
V. Moreno
◽
X. Mirabel
◽
B. Dodger
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Elderly Patients
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Locally Advanced
◽
Neck Squamous Cell Carcinoma
◽
Advanced Head
Download Full-text
A phase I trial of the addition of the CDK 4/6 inhibitor palbociclib to cetuximab in patients with incurable head and neck squamous cell carcinoma (HNSCC).
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.6043
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. 6043-6043
◽
Cited By ~ 3
Author(s):
Loren S. Michel
◽
Jessica C. Ley
◽
Tanya Marya Wildes
◽
Kathryn Trinkaus
◽
Douglas Adkins
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Neck Squamous Cell Carcinoma
Download Full-text
Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial
Radiotherapy and Oncology
◽
10.1016/j.radonc.2019.08.007
◽
2020
◽
Vol 142
◽
pp. 79-84
◽
Cited By ~ 5
Author(s):
Joris B.W. Elbers
◽
Abrahim Al-Mamgani
◽
Margot E.T. Tesseslaar
◽
Michiel W.M. van den Brekel
◽
Charlotte A.H. Lange
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Neck Squamous Cell Carcinoma
◽
Advanced Stage
Download Full-text
Abstract LB-252: Ketogenic diet with concurrent chemoradiation in head and neck squamous cell carcinoma: Pre-clinical and phase I trial results
10.1158/1538-7445.am2018-lb-252
◽
2018
◽
Author(s):
Daniel MA
◽
Carryn Anderson
◽
Samuel N. Rodmann
◽
Kayla Follmer
◽
Visarut Buranasudja
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Ketogenic Diet
◽
Squamous Cell
◽
Phase I Trial
◽
Neck Squamous Cell Carcinoma
◽
Concurrent Chemoradiation
Download Full-text
Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
Oral Oncology
◽
10.1016/j.oraloncology.2007.10.009
◽
2008
◽
Vol 44
(9)
◽
pp. 823-829
◽
Cited By ~ 91
Author(s):
Herbert Riechelmann
◽
Alexander Sauter
◽
Wolfram Golze
◽
Gertraud Hanft
◽
Carsten Schroen
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Neck Squamous Cell Carcinoma
Download Full-text
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Investigational New Drugs
◽
10.1007/s10637-021-01152-z
◽
2021
◽
Author(s):
Grégoire Marret
◽
Nicolas Isambert
◽
Keyvan Rezai
◽
Jocelyn Gal
◽
Esma Saada-Bouzid
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Pi3k Inhibitor
◽
Neck Squamous Cell Carcinoma
Download Full-text
Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02
Radiation Oncology
◽
10.1186/1748-717x-8-40
◽
2013
◽
Vol 8
(1)
◽
pp. 40
◽
Cited By ~ 4
Author(s):
Yungan Tao
◽
Etienne Bardet
◽
Dominique Rosine
◽
Frédéric Rolland
◽
Emmanuelle Bompas
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Neck Squamous Cell Carcinoma
◽
Oral Etoposide
Download Full-text
Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Oral Oncology
◽
10.1016/j.oraloncology.2016.05.011
◽
2016
◽
Vol 58
◽
pp. 41-48
◽
Cited By ~ 43
Author(s):
Loren Michel
◽
Jessica Ley
◽
Tanya M. Wildes
◽
András Schaffer
◽
Anthony Robinson
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Neck Squamous Cell Carcinoma
◽
Cyclin Dependent Kinase
Download Full-text
A phase I trial of pazopanib (suspension formulation) added to a fixed dose of cetuximab in patients with incurable head and neck squamous cell carcinoma (HNSCC).
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.e17028
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. e17028-e17028
Author(s):
Douglas Adkins
◽
Jessica C. Ley
◽
Tanya Marya Wildes
◽
Kathryn Trinkaus
◽
Marilyn Siegel
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Neck Squamous Cell Carcinoma
◽
Fixed Dose
◽
Suspension Formulation
Download Full-text
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma
Radiotherapy and Oncology
◽
10.1016/j.radonc.2010.11.008
◽
2011
◽
Vol 98
(1)
◽
pp. 42-47
◽
Cited By ~ 7
Author(s):
Yungan Tao
◽
Keyvan Rezaï
◽
Etienne Brain
◽
Atoussa Etessami
◽
Antoine Lusinchi
◽
...
Keyword(s):
Squamous Cell Carcinoma
◽
Phase I
◽
Cell Carcinoma
◽
Head And Neck
◽
Squamous Cell
◽
Phase I Trial
◽
Locally Advanced
◽
Neck Squamous Cell Carcinoma
◽
Advanced Head
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close